Immunoreaction with anti-SGLT2 in STZ-administered mice was significantly stronger with malocclusion than without malocclusion, suggesting that malocclusion increases GULT2 expression under hyperglycemia circumstances. The gene discussed is SLC5A2; the disease is Hyperglycemia.